Eligibility, uptake and response to germline genetic testing in women with DCIS

BACKGROUND: Ductal carcinoma in situ (DCIS) is a malignant, yet pre-invasive disease of the breast. While the majority of DCIS have low risk of recurrence, a subset of women with germline pathogenic variants (PV) in cancer predisposition genes are at increased risk for recurrence. Uptake of genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Turza, Lauren, Lovejoy, Leann A., Turner, Clesson E., Shriver, Craig D., Ellsworth, Rachel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459377/
https://www.ncbi.nlm.nih.gov/pubmed/36091166
http://dx.doi.org/10.3389/fonc.2022.918757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459377/
https://www.ncbi.nlm.nih.gov/pubmed/36091166
http://dx.doi.org/10.3389/fonc.2022.918757

Ejemplares similares